Skip to main content
HairCited

米诺地尔(Minoxidil) 用于 雄激素性脱发

A

基于191项研究(19项荟萃分析、21项RCT),共41,495名参与者。159/191项研究显示积极效果。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

结论

Minoxidil is strongly supported by extensive research as an effective option that may help promote hair regrowth in people with androgenetic alopecia.

  • 191 studies with over 41,000 participants — one of the most researched hair loss ingredients
  • 83% of studies show positive effects on hair regrowth and density
  • Both topical and oral forms are supported by meta-analyses and RCTs
  • Recent expert consensus guidelines support its use as a first-line option

Key Study Findings

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo 效果: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None 效果: None None

研究人群: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss 效果: None None

研究人群: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); vs: Placebo 效果: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
Case Reports n=1 Open-label
Plica Neuropathica (Polonica) Secondary to Diffuse Alopecia: A Case Report and Literature Review.
Dose: None vs: None Outcome: None 效果: None None

研究人群: 62-year-old female with diffuse alopecia and plica neuropathica

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study vs: Placebo 效果: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None

Key Statistics

299

研究数量

68291

受试者

Positive

A

等级

Referenced Papers

Journal of the … 2026
Aesthetic plastic surgery 2025 14 次引用
Anais brasileiros de … 2025 7 次引用
Acta dermato-venereologica 2025 4 次引用
European journal of … 2025 3 次引用
Australian prescriber 2025 2 次引用
Acta dermatovenerologica Alpina, … 2025 2 次引用
International journal of … 2025 1 次引用
Journal of clinical … 2025 1 次引用
Skin appendage disorders 2025 1 次引用
Nature reviews. Disease … 2025
Archives of dermatological … 2025
Annals of dermatology 2025
International journal of … 2024 39 次引用
Indian journal of … 2024 14 次引用
Journal of cosmetic … 2024 11 次引用
Journal of clinical … 2024 10 次引用
Facial plastic surgery … 2024 8 次引用
Photodermatology, photoimmunology & … 2024 8 次引用
American family physician 2024 8 次引用
Skin health and … 2024 7 次引用
International journal of … 2024 5 次引用
SAGE open medical … 2024 3 次引用
Vestnik oftalmologii 2024 1 次引用
Drugs 2023 221 次引用
JAAD international 2023 80 次引用
Clinical, cosmetic and … 2023 58 次引用
American journal of … 2023 41 次引用
Anais brasileiros de … 2023 29 次引用
Skin appendage disorders 2023 27 次引用
Archives of dermatological … 2023 16 次引用
Journal der Deutschen … 2023 5 次引用
International journal of … 2023 5 次引用
Journal of cosmetic … 2023 3 次引用
BMJ case reports 2023 2 次引用
Clinics in plastic … 2023 1 次引用
International journal of … 2023 1 次引用
The Journal of … 2022 170 次引用
Faculty reviews 2022 44 次引用
Dermatology and therapy 2022 43 次引用
Dermatologic therapy 2022 41 次引用
Journal of cosmetic … 2022 35 次引用
Journal of cosmetic … 2022 7 次引用
Cureus 2022 3 次引用
Facial plastic surgery … 2022
Journal of cutaneous … 2021 44 次引用
Journal of the … 2021 42 次引用
Actas dermo-sifiliograficas 2021 3 次引用
Expert opinion on … 2020 147 次引用
American journal of … 2020 127 次引用
International journal of … 2020 58 次引用
Indian dermatology online … 2020 31 次引用
Dermatologic clinics 2020 15 次引用
Facial plastic surgery … 2020 15 次引用
Alternative therapies in … 2020 11 次引用
Drug design, development … 2019 320 次引用
Journal of cosmetic … 2019 100 次引用
American journal of … 2019 84 次引用
Expert opinion on … 2019 34 次引用
Bioscience, biotechnology, and … 2019 9 次引用
International journal of … 2018 129 次引用
Journal of the … 2018 114 次引用
Indian journal of … 2018 79 次引用
Lasers in medical … 2018 75 次引用
Dermatologic therapy 2018 63 次引用
Australian journal of … 2018 8 次引用
American family physician 2017 141 次引用
JAMA dermatology 2017 121 次引用
Current clinical pharmacology 2017 62 次引用
Actas dermo-sifiliograficas 2017 17 次引用
BMJ case reports 2017 6 次引用
Deutsches Arzteblatt international 2016 99 次引用
The Cochrane database … 2016 18 次引用
The Medical clinics … 2015 66 次引用
Current problems in … 2015 8 次引用
Der Internist 2015
Lasers in surgery … 2014 243 次引用
Journal of cutaneous … 2014 168 次引用
Expert opinion on … 2014 57 次引用
Skin therapy letter 2014 29 次引用
Journal of drugs … 2014 26 次引用
Giornale italiano di … 2014 8 次引用
Giornale italiano di … 2014
Indian journal of … 2013 196 次引用
Dermatologic clinics 2013 78 次引用
Journal of cosmetic … 2013 62 次引用
International journal of … 2013 61 次引用
Indian journal of … 2013 16 次引用
Facial plastic surgery … 2013 16 次引用
International journal of … 2013
The Cochrane database … 2012 15 次引用
Expert opinion on … 2010 264 次引用
Current opinion in … 2009 54 次引用
Seminars in cutaneous … 2009 4 次引用
American family physician 2009
Current opinion in … 2008 31 次引用
Nihon rinsho. Japanese … 2008 6 次引用
Endocrinology and metabolism … 2007 33 次引用
Clinical interventions in … 2007
Acta dermatovenerologica Alpina, … 2005
Annual review of … 2004 664 次引用
Revue medicale de … 2004
The journal of … 2003 102 次引用
Praxis 2003 28 次引用
American family physician 2003 2 次引用
American family physician 2003
Clinical and experimental … 2002 61 次引用
Therapeutische Umschau. Revue … 2002 4 次引用
American journal of … 2000 18 次引用
Southern medical journal 2000
International journal of … 1999 16 次引用
Journal of cutaneous … 1999
Journal of the … 1999
International journal of … 1999
American family physician 1999
Dermatologic clinics 1998 121 次引用
Annales de dermatologie … 1997
Journal of the … 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

topical:
2-5% solution, twice daily

上限: 5% topical solution

研究中使用的剂量

剂量 持续时间 效果 N
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
None -- Mixed 1
varies by agent and study -- Positive --
None -- Positive --
None -- Mixed --

最佳服用时间: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

已报告的副作用

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

已知相互作用

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

可耐受最高摄入量: 5% topical solution

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does 米诺地尔(Minoxidil) help with 雄激素性脱发?
Based on 299 studies with 68,291 participants, there is strong evidence from multiple clinical trials that 米诺地尔(Minoxidil) may support 雄激素性脱发 management. Our evidence grade is A (Strong Evidence).
How much 米诺地尔(Minoxidil) should I take for 雄激素性脱发?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 米诺地尔(Minoxidil)?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 米诺地尔(Minoxidil) and 雄激素性脱发?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 299 peer-reviewed studies with 68,291 total participants. The overall direction of effect is positive.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。